Status:
COMPLETED
High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Dual therapy for Helicobacter Pylori including a proton pump inhibitor (PPI) and amoxicillin. Amoxicillin has low resistance rate as well as low percentage of side effects. No trial has examined the t...
Eligibility Criteria
Inclusion
- Participants with non-ulcer functional dyspepsia or peptic ulcer disease
- Ability and willingness to participate in the study and to sign and give informed consent
- Confirmed H. pylori infection
Exclusion
- Less than 18 years old
- With previous gastric surgery
- Major systemic diseases
- Pregnancy or lactation
- Allergy to any of the study drugs Administration of antibiotics, bismuth, antisecretory drugs in 8 weeks prior to inclusion
Key Trial Info
Start Date :
January 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2018
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03405584
Start Date
January 3 2018
End Date
November 2 2018
Last Update
November 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127